APA (7th ed.) Citation

M, S., & M, B. (2017). Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies. Current oncology reports, 19(3), 19. https://doi.org/10.1007/s11912-017-0579-4

Chicago Style (17th ed.) Citation

M, Schoumacher, and Burbridge M. "Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies." Current Oncology Reports 19, no. 3 (2017): 19. https://doi.org/10.1007/s11912-017-0579-4.

MLA (9th ed.) Citation

M, Schoumacher, and Burbridge M. "Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies." Current Oncology Reports, vol. 19, no. 3, 2017, p. 19, https://doi.org/10.1007/s11912-017-0579-4.